KOR  ENG
  • IR

  • AbClon’s strong foundations and innovative platforms will help drive the future of
    personalized medicine and safeguard the health and hopes of families.

IR자료

제목 [키움증권] 우리도 4-1BB 합니다.
첨부파일 키움증권_허혜민_20190228.pdf (512.5K) 날짜 2019-02-28 조회 553

1. 제목 : 우리도 4-1BB 합니다.

 

2. 기관명 : 키움증권

 

3. 작성자 : 허혜민 연구원

 

4. 분량 : 3page

 

5. 발간일 : 2019. 2.28

Designed by CHAIRONE
© AbClon. All rights reserved.